Hypertriglyceridemia and Coronary Artery Disease - An Update

Indian Heart Journal

Volumn 56, Issue 1, 2004, Pages 21-26

  Ravi, G R ^a   Pradeepa, R ^a   Mohan, V ^a,b  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b Madras Diabetic Research Foundation (MDRF)   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEZAFIBRATE; DIURETIC AGENT; ESTROGEN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; ORAL CONTRACEPTIVE AGENT; STEROID; TRIACYLGLYCEROL;

CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; DYSLIPIDEMIA; EPIDEMIOLOGICAL DATA; HUMAN; HYPERTRIGLYCERIDEMIA; LIVER TOXICITY; MYOPATHY; OBESITY; PATHOGENESIS; POPULATION RESEARCH; POSTPRANDIAL STATE; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL CLASS; SOCIAL STATUS;

CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTRIGLYCERIDEMIA; INDIA; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 1942469519     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease. N Engl J Med 1980; 302: 1383-1389
2. Austin MA. Plasma triglyceride as a risk factor for cardiovascular disease. Can J Cardiol 1998; 14 (Suppl): 14B-17B
3. Coughlan BJ, Sorrentino MJ. Does hypertriglyceridemia increase risk for CAD? Growing evidence suggests it plays a role. Postgrad Med 2000; 108: 77-84
4. Nakaya N. Hypertriglyceridemia as a cause of atherosclerosis. Nippon Rinsho 2002; 60: 860-867
5. Gotto AM Jr. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Am Heart J 2002; 144 (6 Suppl); S33-S42
6. Gofmann JW, De Lalla O, Glazier F. The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary artery disease. Plasma 1954, 2: 413-484
7. Albrink MJ, Mann EB. Serum triglycerides in coronary artery disease. Arch Intern Med 1959; 103: 4-8
8. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991; 11: 2-14
9. Mukherjee M, Desai H, Soneji SL. Triglyceride and coronary heart disease. J Assoc Physicians India 1994; 42: 463-465
10. Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973; 48: 950-958
11. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR. Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study. Am J Epidemiol 1986; 124: 624-632
12. Aberg H, Lithell H, Selinus I, Hedstrand H. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris: Results from a 10-year follow-up of Uppsala primary preventive study. Atherosclerosis 1985; 54: 89-97
13. Glynn RJ, Rosner B, Silbert JE. Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men. Circulation 1982; 66: 724-731
14. Carlson LA, Bottiger LE. Risk factors for ischaemic heart disease in men and women: Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 1985; 218: 207-211
15. Bainton D, Miller NE, Bolton CH, Yarnell JW, Sweetnam PM, Baker IA, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J 1992; 68: 60-66
16. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-219
17. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993; 328: 1220-1205
18. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112: 432-437
19. West KM, Ahuja MM, Bennett PH, Czyzyk A, De Acosta OM, Fuller JH, et al. The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983; 6: 361-369
20. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989; 32: 300-304
21. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster Study. Am J Cardiol 1992; 70: 733-737
22. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 1992; 85: 37-45
23. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996; 77: 1179-1184
24. Mckeigue PM, Miller GJ, Marmot MG. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol 1986; 41: 597-609
25. Rani SS, Rema M, Deepa R, Premalatha G, Ravikumar R, Anjana M, et al. The Chennai Urban Population Study (CUPS) - methodological details - (CUPS Paper No. 1). Int J Diab Dev Countries 1999; 19: 149-57
26. Pradeepa R, Deepa R, Rani SS, Premalatha G, Saroja R, Mohan V. Socioeconomic status and dyslipidaemia in a South Indian population: The Chennai Urban Population Study (CUPS 11). Natl Med J India 2003; 16: 73-78
27. Mohan V, Deepa R, Rani SS, Premalatha G: Chennai Urban Population, study (CUPS No. 5). Prevalence of coronary artery disease and its relationship to lipids in a selected population in south India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001; 38: 682-687
28. Premalatha G, Rani SS, Deepa R, Markovitz J, Mohan V. Prevalence and risk factors of peripheral vascular disease in a selected south Indian population-the Chennai Urban Population Study (CUPS). Diabetes Care 2000; 23: 1295-1300
29. Rajmohan L, Deepa R, Mohan A, Mohan V. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients. Indian Heart J 2000; 52: 400-406
30. Assmann G, Brewer HB Jr. Genetic (primary) forms of hypertriglyceridemia. Am J Cardiol 1991; 68: 13A-16A
31. Mancini M, Steiner G, Betteridge DJ, Pometta D. Acquired (secondary) forms of hypertriglyceridemia. Am J Cardiol 1991; 68: 17A-21A
32. Miller M. Is hypertriglyceridaemia an independent risk factor for coronary heart disease: The epidemiological evidence. Eur Heart J 1998; 19(Suppl): H18-H22
33. Gotto M. Triglyceride, the forgotten risk factor. Circulation 1998; 97: 1027-1028
34. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998; 97: 1029-1036
35. Benlian P, De Gennes JL, Foubert L, Zhang H, Gagne SE, Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 1996; 335: 848-854
36. Heine RJ, Dekker JM. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia 2002; 45: 461-475
37. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-1345
38. Sharrett AR, Heiss G, Chambless LE, Boerwinkle E, Coady SA, Folsom AR, et al. Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: The Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001; 21: 275-281
39. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-485
40. Patsch JR. Triglyceride-rich lipoproteins and atherosclerosis. Atherosclerosis 1994; 110 (Suppl): S23-S26
41. Syvänne M, Taskinen MR. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 1997; 350 (Suppl 1): S120-S123
42. Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997; 129: 79-88
43. Anderson RA, Evans ML, Ellis GR, Graham J, Morris K, Jackson SK, et al. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 2001; 154: 475-483
44. Summers LK, Samra JS, Frayn KN. Impaired postprandial tissue regulation of blood flow in insulin resistance: a determinant of cardiovascular risk? Atherosclerosis 1999; 147: 11-15
45. Golay A. Are postprandial triglyceride and insulin abnormalities neglected cardiovascular risk factors in type 2 diabetes? Eur J Clin Invest 2000; 30 (Suppl): 12-18
46. Bae JH, Bassenge E, Kim KB, Kim YN, Kim KS, Lee HJ et al. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 2001; 155: 517-523
47. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002; 106: 1211-1218
48. Berthezene F. Hypertriglyceridemia: cause or consequence of insulin resistance? Horm Res 1992; 38: 39-40
49. De Man FH, Cabezas MC, Van Barlingen HH, Erkelens DW, de Bruin TW. Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis. Eur J Clin Invest 1996; 26: 89-108
50. Malmstrom R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Jarvinen H, et al. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 1997; 40: 454-462
51. Shafrir E, Raz I. Diabetes: mellitus of lipidus? Diabetologia 2003; 46: 433-440
52. McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 1999; 42: 128-138
53. Breuer HW. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Curr Med Res Opin 2001; 17: 60-73
54. Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adusts (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
55. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-Summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 2003; 41: 159-168